Navigation Links
NIH SPECIAL Science SERIES: Groundbreaking Molecules to Revolutionize Autophagy Induction for Treating Huntington’s Disease, and potentially Alzheimer’s and Parkinson's
Date:2/1/2017

One Million Solutions in Health has a one-of-a-kind partnership with the NIH to share new technologies and findings through the NIH Special Science Series. These technologies have been available for licensing and/or collaboration projects. This webinar highlights "Groundbreaking Molecules that will Revolutionize Autophagy Induction for Treating Huntington’s Disease, and potentially Alzheimer’s and Parkinson’s Diseases" and is presented by Dr. Lori Griner, Post-doctoral Research Fellow, NICHD, NIH and Dr. Melvin L. DePamphilis, Section Chief, NICHD, NIH.

This groundbreaking discovery features five small molecules that lower mutant huntingtin protein (HTT) in primary cells from Huntington’s, Alzheimer’s and Parkinson’s patients, and a cell culture model for Huntington’s disease. These target a major strategy in the treatment of these diseases in a new and unique way.

These small molecules were discovered based on their ability to induce autophagy, a cellular process whereby components of the cytoplasm are degraded. Current progress in the autophagy and Huntington’s disease fields show that autophagy induction in in vitro and in vivo models, lowers mutant HTT protein and improves disease symptoms, making autophagy induction a promising strategy for treating Huntington’s disease, and potentially Alzheimer’s and Parkinson’s disease patients.

Currently, there is a need for safe and effective inducers of autophagy for patients. More importantly, there is no cure for Huntington’s, Alzheimer’s or Parkinson’s — with the current treatment only targeting the minimization of symptoms. Due to the large unmet need of effective treatment options for these types of patients, and the promise of autophagy induction as a therapeutic strategy, this technology holds an enormous value.

Review the webinar here: "Groundbreaking Molecules that will Revolutionize Autophagy Induction for Treating Huntington’s Disease, and potentially Alzheimer’s and Parkinson’s Diseases".

ABOUT ONE MILLION SOLUTIONS IN HEALTH:

As a not-for-profit, the goal of One Million Solutions in Health™ is to shape health care by sharing solutions and, importantly, to accelerate the discovery, development and delivery ... of innovative cures, treatments and preventative measures for patients around the world. By facilitating efforts to ensure organizations can Connect, Learn + Share, Innovate and Collaborate, our vision is to improve health care delivery, accelerate life sciences research and share patient and consumer-focused ideas and solutions.

By engaging scientists, entrepreneurs, investors, innovators, industry experts, health care professionals, and patients across various disciplines, and from around the world, we can utilize the power of the internet to disrupt things in a positive and transformative way to accelerate the movement of new solutions and scientific discoveries from the scientist to the patient.

The Technology Evaluation Consortium (TEC) brings together life sciences and/or health care companies and technology providers, and other relevant partners (e.g., government and Universities) to evaluate and validate technologies or services in a collaborative environment. The model empowers technology providers and industry end users to collectively assess a number of technologies in a cost-effective manner, producing a depth and breadth of results that no company can achieve alone.

We are on our way towards accelerating high-potential innovations, catalyzing investment and increasing awareness of, and support for, important ideas to improve health and save lives. We are thrilled to have you be a part of this transformative journey!

IF YOU HAVE A TECHNOLOGY, SCIENTIFIC DISCOVERY OR MEDICAL SOLUTION YOU WOULD LIKE US TO HELP SHARE WITH THE WORLD, CONTACT US.

For more information: http://www.onemillionsolutionsinhealth.org

CONTACT:

One Million Solutions in Health™
Dawn Van Dam
Executive Director & CEO
Email: dawn.vandam(at)onemillionsolutionsinhealth(dot)org
Phone: 416-402-8274
Twitter: @DawnVanDam

Read the full story at http://www.prweb.com/releases/2017/02/prweb14033194.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program
2. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
3. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
4. MBC Helps Internal Medicine Specialists in Florida Tackle Medicare & Medicaid Fee Parity Initiative Challenges
5. Organic Rust Remover Gives Out 10% Discount for Mothers' Day Special Relates My Cleaning Products
6. PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits
7. Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same
8. HealthEconomics.Com Launches a New Specialty Pharma Newsletter to Worldwide Community of Industry Insiders Within Specialty Pharmaceuticals
9. $999 Special Pricing for Chicago Certified ScrumMaster Training, August 19th and 20th (14 PDUs)
10. Avail the Special Pricing of $999 till Aug 1st, 2013 for the Certified ScrumMaster Training in Orlando on August 22- 23 (14 PDUs)
11. Midwest Specialty Distribution Plant Expanding as Companies Focus on Sales and Distribution Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Myrtle Beach, SC (PRWEB) , ... April 26, ... ... for the mind, has teamed up with NASA to showcase the future of ... NASA’s Space Launch System (SLS) rocket and Orion spacecraft and includes a guest ...
(Date:4/26/2017)... RESTON, Va. (PRWEB) , ... April 26, 2017 ... ... to make headlines and drive high-level conversations among healthcare industry stakeholders, the discussion ... Healthcare Environment – taking place May 15-18, 2017 in Los Angeles, Calif. Hosted ...
(Date:4/25/2017)... PROVIDENCE, R.I. , April 25, 2017 /PRNewswire/ ... EpiVax, Inc. ("EpiVax") has licensed its novel immune-modulating technology ... in autoimmune disease and allergy. Tregitopes, ... discovered in human immunoglobulin by EpiVax CEO ... Martin. Similar to intravenous immunoglobulin G, an autoimmune ...
(Date:4/24/2017)... April 24, 2017  Dante Labs announced today the offer ... 850 (ca. $900). While American individuals have been able to ... Europeans can access WGS below EUR 1,000. The ... leveraging genetic information to make informed decisions about disease monitoring, ... ...
Breaking Biology Technology:
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... its 2016 Annual Report on Form 10-K on Thursday April 13, ... ... the Investor Relations section of the Company,s website at http://www.nxt-id.com ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):